
Early-stage biotechnology company developing RNA-based therapeutics
miRecule develops next-generation RNA therapeutics to treat a variety of diseases including cancer and muscular dystrophy.
Boutique Venture Partners backs authentic founders who transform industries and create new ones in healthcare and life sciences.